Stay updated on Chemo +/- Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Chemo +/- Nivolumab in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version maintenance update rather than a change to the clinical study information presented.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check56 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No visible changes to the page content or study details.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page now lists Revision: v3.4.2 as an addition and Revision: v3.4.1 as a deletion. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedPlatform revision updated from Revision: v3.4.0 to v3.4.1; no substantive changes to the study content, eligibility criteria, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Chemo +/- Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.